GHRP-2 (10mg) protocols focus on this synthetic growth hormone-releasing peptide studied for its ability to stimulate endogenous growth hormone (GH) release via ghrelin receptor activation. It may support muscle growth, fat metabolism, recovery, and improved sleep quality. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.
Concise summary of the subcutaneous regimen.
Suggested approach for the 10 mg vial format.
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic peptide that binds to the ghrelin (growth hormone secretagogue) receptor in the pituitary and hypothalamus. This stimulates pulsatile release of growth hormone independently of growth hormone-releasing hormone (GHRH).
By increasing endogenous GH levels, GHRP-2 may indirectly elevate IGF-1 (Insulin-like Growth Factor 1), which plays a key role in muscle growth, tissue repair, and metabolism. It may also influence appetite signaling and gastrointestinal motility due to its ghrelin-mimetic activity.
Observations based on preclinical and early-stage research.
Potential Benefits:
Possible Side Effects: